Impact of the <scp>COVID</scp>‐19 pandemic on the glycemic control in people with diabetes mellitus: A retrospective cohort study

Ohkuma, Kanako; Sawada, Mikio; Aihara, Masakazu; Doi, Shunsuke; Sekine, Rika; Usami, Satoshi; Kubota, Naoto; Yamauchi, Toshimasa

doi:10.1111/jdi.14021

Cited by 3 publications

(4 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The observed increase in HbA1c values on a population level as well as on an individual level has been previously reported in multiple studies [13][14][15]. In a systematic review investigating glycemic control in patients with diabetes, a meta-analysis showed an HbA1c increase of 0.14% (−0.13 to 0.40) in persons with T2D, based on eight studies [14].…”

Section: Previous Studiessupporting

confidence: 53%

The Impact of the COVID-19 Pandemic in The Netherlands on Primary Healthcare Use and Clinical Outcomes in Persons with Type 2 Diabetes

van den Berg,

Blom,

Swart

et al. 2023

COVID

View full text Add to dashboard Cite

The COVID-19 pandemic has had a significant impact on healthcare systems worldwide, including the postponing or canceling of appointments and procedures for type 2 diabetes (T2D) care by general practitioners (GPs) in the Netherlands. The aim of this study was to investigate the impact of the COVID-19 pandemic on primary healthcare use and clinical measurements for people with T2D. Additionally, we aimed to determine if changes were observed among specific risk groups: (1) persons 70 years or older, or below 70 years, (2) patients who were meeting their HbA1c targets and those who were not, and (3) patients with high-risk and non-high-risk T2D. This retrospective cohort study among persons with T2D was conducted using data from the DIAbetes MANagement and Treatment (DIAMANT) data infrastructure, deriving data from electronic medical records of Dutch GPs. The study assessed GP visit counts, and counts and values of clinical measurements, including hemoglobin A1c (HbA1c), body mass index (BMI), low-density lipoprotein (LDL) cholesterol, and systolic blood pressure (SBP). Adjusted negative binomial (NB) regression and generalized estimating equations (GEE) models were used to estimate GP visit counts and population averages of clinical measurements, respectively, comparing 2019 (pre-pandemic) with 2020 (during the pandemic). Changes in specific groups were examined by stratifying outcomes for the aforementioned subgroups. The cohort consisted of 182,048 patients with T2D (47% female, mean age 69 ± 13 years) on 1 March 2019, of which 168,097 persons (92%) still contributed follow-up data in 2020. We observed an increase in total GP visits in 2020, with an adjusted rate ratio (RR) of 1.09 (95% CI 1.08–1.09). The frequency increased for office visits (RR 1.06; 1.06–1.07) and phone calls (RR 1.33; 1.31–1.35) but remained stable for home visits (RR 1.02; 0.99–1.04). On both population and individual levels, HbA1c values increased in 2020 by 1.65 (1.59–1.70) mmol/mol compared to 2019. Observed changes in 2020 for BMI, LDL, and SBP values were also statistically significant but small. Subgroup stratifications showed higher scores of all clinical measurements in younger persons (<70 years), those who met their HbA1c target, and non-high-risk T2D patients than their respective high-risk subgroups. During the first year of the COVID-19 pandemic in the Netherlands, changes in primary healthcare use were observed among persons with T2D, with an increase in GP office visits and phone calls and a decreased number of clinical measurements and GP home visits. HbA1c levels increased among patients with T2D in 2020. Further research is necessary to determine the impact of the COVID-19 pandemic on long-term clinical outcomes and (long-term) T2D complications.

show abstract

Section: Previous Studiessupporting

confidence: 53%

The Impact of the COVID-19 Pandemic in The Netherlands on Primary Healthcare Use and Clinical Outcomes in Persons with Type 2 Diabetes

van den Berg,

Blom,

Swart

et al. 2023

COVID

View full text Add to dashboard Cite

show abstract

“…Several studies found that the COVID-19 pandemic led to a notable increase in GDM prevalence when using the gold standard diagnostic method. This increase was attributed to exposure to various stressful factors such as lockdowninduced restrictions, heightened anxiety and depression, and alterations in dietary habits 36,[52][53][54] . However, this review suggested that the incidence of GDM appeared to decrease when new screening methods were introduced during the pandemic.…”

Section: Discussionmentioning

confidence: 99%

Comparing the screening methods for gestational diabetes mellitus before and during the COVID‐19 pandemic: A systematic review

Sun,

McKeaveney,

Noble

et al. 2023

J of Diabetes Invest

View full text Add to dashboard Cite

BackgroundThe oral glucose tolerance test (OGTT) is the gold standard for detecting gestational diabetes mellitus (GDM). However, during the COVID‐19 pandemic, screening practices were reevaluated due to the risk of infection associated with the prolonged hospital visit required for the OGTT. Some countries have published novel screening protocols for GDM, suggesting the utilization of hemoglobin A1c (HbA1c), random plasma glucose (RPG), or fasting plasma glucose (FPG) in favor of OGTTs during the pandemic. Therefore, differences in screening methods before and after the epidemic need to be examined.MethodsA systematic search was carried out across five electronic databases (Cinahl, Medline, Embase, Pubmed, and Web of Science) between 2016 and 2023. The Critical Appraisal Skills Programme (CASP) checklist for cohort studies was used to evaluate the quality of included papers.ResultsA total of 13 eligible studies were included. Prior to the COVID‐19 pandemic, the OGTT was the recommended measure to screen GDM, internationally based on various official guidelines. During the pandemic, it was recommended that HbA1c or FPG, or RPG be used as a substitute for OGTTs. However, the new methods have low sensitivity, may not reflect accurately the prevalence of GDM, and may lead to many false‐negative results in women and to adverse pregnancy and neonatal outcomes.ConclusionThe new screening methods for GDM have poor accuracy and a high risk of adverse pregnancy outcomes. Comparatively, targeted screening tests to detect GDM according to the risk level are more effective in an emergency. In the future, the alternatives to OGTTs still need to be further explored in more depth.

show abstract

“…Theo nghiên cứu của Kanako Ohkuma, tổng hợp lại nhiều nghiên cứu trước đây về sự tác động của COVID-19 tới hơn 4000 người bệnh ĐTĐ, trung bình HbA1c trước và sau mắc COVID-19 lần lượt là 7.05 ± 0.01% vs. 7.11 ± 0.01%, p <0.001 7 .…”

Section: Bàn Luậnunclassified

“…Ở nghiên cứu của Kanako Ohkuma, tác giả cũng cho thấy các chỉ số mỡ máu có sự thay đổi đáng kể về mặt thống kê, với trung bình Cholesterol trước và sau mắc COVID-19 là 4,78 ± 0.53; 4,79 ± 0.55 và p <0.001 7 .…”

Section: Bàn Luậnunclassified

Đánh giá thực trạng kiểm soát đường huyết và một số yếu tố liên quan ở người bệnh đái tháo đường típ 2 sau mắc Covid-19 3 tháng tại Bệnh viện Nội tiết Nghệ An

Bùi,

Vũ

2024

vjde

View full text Add to dashboard Cite

Mục tiêu: Khảo sát thực trạng kiểm soát đường huyết và một số yếu tố liên quan ở người bệnh ĐTĐ típ 2 sau mắc COVID-19 3 tháng tại Bệnh viện Nội tiết Nghệ An. Đối tượng và phương pháp nghiên cứu: Hồi cứu, mô tả cắt ngang có phân tích trên 179 người bệnh đái tháo đường típ 2 mắc COVID-19 tại Bệnh viện Nội tiết Nghệ An. Kết quả: tuổi trung bình 64,39 ± 9,87 tuổi, thời gian mắc ĐTĐ chủ yếu là > 5 năm với 77,7%, thể trạng bình thường chiếm 50,8%, thừa cân, béo phì chiếm 46,4%. Người bệnh mắc COVID-19 trong thời gian trung bình 7,56 ± 1,49 ngày, với phần lớn là ở mức độ nhẹ và không triệu chứng, chiếm 99,4%. Phần lớn người bệnh kiểm soát huyết áp tốt với 73,7%. Phương pháp điều trị chủ yếu là phối hợp thuốc viên hoặc phối hợp thuốc viên và Insulin. Sự thay đổi chỉ số Glucose máu đói, HbA1c, Cholesterol và LDL-C trước và sau mắc COVID-19 có ý nghĩa thống kế với p = 0,000 < 0,05. Tỉ lệ người bệnh kiểm soát tốt Glucose máu đói, HbA1c và đồng thời cả 2 chỉ số sau khi mắc COVID-19 (lần lượt: 17,3%, 17,9% và 8,4%) là kém hơn so với trước mắc COVID-19 (lần lượt: 34,1%, 31,8% và 24,0%). Kết luận: Tỉ lệ người bệnh kiểm soát tốt đường huyết, mỡ máu sau mắc COVID-19 chiếm tỉ lệ thấp. Những người bệnh ĐTĐ sau khi mắc COVID-19 khó khăn hơn trong việc kiểm soát đường huyết, đặc biệt ở những đối tượng lớn tuổi, thể trạng thừa cân, thời gian mắc ĐTĐ càng lâu, mức độ mắc COVID-19 càng nặng.

show abstract

Impact of the COVID‐19 pandemic on the glycemic control in people with diabetes mellitus: A retrospective cohort study

Cited by 3 publications

References 40 publications

The Impact of the COVID-19 Pandemic in The Netherlands on Primary Healthcare Use and Clinical Outcomes in Persons with Type 2 Diabetes

The Impact of the COVID-19 Pandemic in The Netherlands on Primary Healthcare Use and Clinical Outcomes in Persons with Type 2 Diabetes

Comparing the screening methods for gestational diabetes mellitus before and during the COVID‐19 pandemic: A systematic review

Đánh giá thực trạng kiểm soát đường huyết và một số yếu tố liên quan ở người bệnh đái tháo đường típ 2 sau mắc Covid-19 3 tháng tại Bệnh viện Nội tiết Nghệ An

Contact Info

Product

Resources

About